| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.5B | $9.0B | $9.4B | $8.7B | $7.3B | $5.3B | $2.3B | $2.3B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $1.0B | $0.8B | $1.0B | $1.0B | $0.7B | $0.7B | $1.0B | $1.0B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $-0.7B | $-2.9B | $0.6B | $2.1B | $0.4B | $-1.7B | $-0.1B | $-0.2B |
| EPS (Basic) | $-2.41 | $-9.34 | $1.97 | $5.43 | $-0.27 | $-11.44 | $-0.83 | $-1.20 |
| EPS (Diluted) | $-2.43 | $-9.34 | $1.39 | $3.36 | $-0.27 | $-11.44 | $-0.83 | $-1.20 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $22.3B | $21.8B | $24.6B | $22.5B | $19.8B | $16.9B | $24.6B | $21.4B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.6B | $0.6B | $0.8B | $0.9B | $2.3B | $1.1B | $0.9B | $1.1B |
| Total Liabilities | $22.8B | $21.6B | $21.5B | $19.9B | $16.8B | $16.8B | $22.7B | $20.3B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $-0.5B | $0.2B | — | — | $3.0B | $1.8B | $1.8B | $1.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.6B | $2.2B | $2.5B | $2.5B | $1.8B | $1.0B | $2.9B | — |
| Investing Cash Flow | $-2.0B | $-2.9B | $-4.0B | $-4.2B | $-3.5B | $4.6B | $-4.4B | $-3.0B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $0.4B | $0.7B | $1.3B | $0.5B | $2.8B | $-5.4B | $1.5B | — |